La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Vir Biotechnology Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Vir Biotechnology has a total shareholder equity of $1.4B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.7B and $235.9M respectively.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
US$0
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | US$1.15b |
| Patrimonio netto | US$1.43b |
| Totale passività | US$235.89m |
| Totale attività | US$1.67b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analysts Are Updating Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates After Its Second-Quarter Results
Aug 03
Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis
Jul 17Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Boosting Their Estimates
May 05Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
May 03Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
Feb 28Sticking With Vir Biotechnology
Jan 17Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Slashed This Year's Revenue Estimates By 37%
Aug 07Revenues Working Against Vir Biotechnology, Inc.'s (NASDAQ:VIR) Share Price Following 42% Dive
Jul 24Analysts Just Shaved Their Vir Biotechnology, Inc. (NASDAQ:VIR) Forecasts Dramatically
Feb 28Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jan 07Vir Biotechnology: Focus On Hepatitis B Development Could End Up Paying Off
Oct 12Vir Biotech gains 12% as U.S. govt. inks multi-year deal worth up to $1B
Oct 04Vir begins dosing in mid-stage study of VIR-2218, VIR-3434 for hepatitis D virus
Sep 22Analisi della posizione finanziaria
Passività a breve termine: VIR's short term assets ($1.2B) exceed its short term liabilities ($96.4M).
Passività a lungo termine: VIR's short term assets ($1.2B) exceed its long term liabilities ($139.5M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: VIR is debt free.
Riduzione del debito: VIR had no debt 5 years ago.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: VIR has sufficient cash runway for more than a year based on its current free cash flow.
Previsione Cash Runway: VIR has sufficient cash runway for 2.1 years if free cash flow continues to grow at historical rates of 4.6% each year.